Patent ID: 9205107
Filing Date: 2015-12-08
Classification: A61K,A61P,C08F,C08G,Y10T

Abstract:
1. A pharmaceutical composition comprising a proton-binding, crosslinked amine polymer comprising the residue of an amine corresponding to Formula 2 or a salt thereof: wherein m and n are independently non-negative integers; R X X each X z is a non-negative number; the crosslinked amine polymer has an equilibrium swelling ratio in deionized water of 5 or less, and the crosslinked amine polymer binds at least 3 mmol of chloride per gram and a molar ratio of chloride ions to phosphate ions of at least 1:1, respectively, when added at a concentration of 2.5 mg/ml to an interfering ion buffer and incubated for one hour at 37° C. wherein the interfering ion buffer is a solution of 36 mM NaCI, 20 mM NaH